ArticleBMC infectious diseases2025

Cefiderocol therapy among immunocompromised adult patients: a descriptive analysis from a prospective, multicentre cohort study.

Andrea Lombardi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.